Most linked-to categories

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

1. Drugs‏‎ (777 members)
2. Intravenous medications‏‎ (381 members)
3. Oral medications‏‎ (369 members)
4. Disease-specific pages‏‎ (271 members)
5. Stub‏‎ (109 members)
6. Investigational drugs‏‎ (93 members)
7. FDA approved drugs‏‎ (82 members)
8. WHO Essential Cancer Medicine‏‎ (79 members)
9. General reference pages‏‎ (78 members)
10. Non-small cell lung cancer medications‏‎ (74 members)
11. Subcutaneous medications‏‎ (71 members)
12. Null regimens‏‎ (70 members)
13. Breast cancer medications‏‎ (70 members)
14. Mutation-specific medications‏‎ (68 members)
15. Diffuse large B-cell lymphoma medications‏‎ (62 members)
16. EMA approved drugs‏‎ (60 members)
17. Biomarker-specific pages‏‎ (53 members)
18. Protein expression-specific medications‏‎ (47 members)
19. Colorectal cancer medications‏‎ (46 members)
20. Historical regimens‏‎ (45 members)
21. Follicular lymphoma medications‏‎ (45 members)
22. Classical Hodgkin lymphoma medications‏‎ (44 members)
23. Neutral‏‎ (44 members)
24. Mantle cell lymphoma medications‏‎ (43 members)
25. B-cell acute lymphoblastic leukemia medications‏‎ (42 members)
26. Prostate cancer medications‏‎ (42 members)
27. Example chemotherapy order sets‏‎ (42 members)
28. Antineoplastic monoclonal antibodies‏‎ (41 members)
29. Esophageal cancer medications‏‎ (41 members)
30. Hematology medications‏‎ (41 members)
31. Acute myeloid leukemia medications‏‎ (40 members)
32. PMDA approved drugs‏‎ (38 members)
33. Multiple myeloma medications‏‎ (38 members)
34. Discontinued drugs‏‎ (37 members)
35. Hepatocellular carcinoma medications‏‎ (35 members)
36. Chronic lymphocytic leukemia medications‏‎ (34 members)
37. Emesis prevention‏‎ (34 members)
38. Gastric cancer medications‏‎ (34 members)
39. Alkylating agents‏‎ (34 members)
40. Melanoma medications‏‎ (34 members)
41. Irritant‏‎ (33 members)
42. Biosimilars‏‎ (33 members)
43. Peripheral T-cell lymphoma medications‏‎ (33 members)
44. Soft tissue sarcoma medications‏‎ (32 members)
45. Intramuscular medications‏‎ (31 members)
46. Tyrosine kinase inhibitors‏‎ (30 members)
47. FDA approved in 2018‏‎ (30 members)
48. Small cell lung cancer medications‏‎ (30 members)
49. Health Canada approved drugs‏‎ (29 members)
50. Waldenström macroglobulinemia medications‏‎ (29 members)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)